6533b81ffe1ef96bd1276fee

RESEARCH PRODUCT

685 EFFICACY OF INTRANASAL FENTANYL SPRAY (INFS) VERSUS ORAL TRANSMUCOSAL FENTANYL CITRATE (OTFC) FOR BREAKTHROUGH CANCER PAIN: OPEN‐LABEL CROSSOVER TRIAL

Andrew DaviesLukas RadbruchSebastiano MercadanteL. PopperLars Korsholm

subject

medicine.medical_specialtyAnesthesiology and Pain MedicineIntranasal Fentanyl Spraybusiness.industryAnesthesiamedicineOpen labelCancer painbusinessCrossover studyFentaNYL CitrateSurgeryhttps://doi.org/10.1016/s1090-3801(09)60688-1